Product NDC: | 0378-0014 |
Proprietary Name: | Methotrexate |
Non Proprietary Name: | methotrexate |
Active Ingredient(s): | 2.5 mg/1 & nbsp; methotrexate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-0014 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA081235 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111110 |
Package NDC: | 0378-0014-50 |
Package Description: | 5000 TABLET in 1 BOTTLE, PLASTIC (0378-0014-50) |
NDC Code | 0378-0014-50 |
Proprietary Name | Methotrexate |
Package Description | 5000 TABLET in 1 BOTTLE, PLASTIC (0378-0014-50) |
Product NDC | 0378-0014 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methotrexate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111110 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | METHOTREXATE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |